Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,262.30 +255.01 1.96%
Hang Seng 21,169.70 -56.19 -0.26%
S&P/ASX 200 4,843.80 +29.45 0.61%
  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

ILMN:US

71.6900 USD 1.0700 1.52%

As of 20:10:00 ET on 06/18/2013.

Company Profile for Illumina Inc (ILMN)

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Contact Information

Illumina Inc

9885 Towne Centre Drive
San Diego, CA 92121
United States
Phone: 1-858-202-4500
Fax: 1-858-202-4766

Key Executives for Illumina Inc (ILMN)

Jay T FlatleyPresident/CEOMarc A StapleySenior VP/CFO
Mostafa RonaghiSenior VP/CTOTristan B OrpinSenior VP/Chief Commercial Ofcr
Charles E DadswellSenior VP/Secy/General CounselGregory F HeathSenior VP/Gen Mgr:Diagnostics
Christian O HenrySenior VP/Gen Mgr:Genomic SystemsMark L LewisSenior VP/Gen Mgr: Molecular
Matthew L PosardSenior VP/Gen Mgr:TranslationalNicholas J Naclerio "Nick"Senior VP:Corporate
Paul BianchiSenior VP:Human ResourcesRebecca ChambersSenior Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil